About 100 reports

  • Eye Cancers

MARKET ##.

  • Diagnostics
  • DNA
  • Pathology
  • World
  • Company Financials
  • 6.5.2 EYE CANCER
  • SYMPTOMS AND TREATMENT FOR EYE CANCER

Global Ophthalmic Drugs & Devices Market Forecast 2017-2025 ## RESEARCH SCOPE ##. ## STUDY GOALS ##. ## SCOPE OF MARKET STUDY ##. ## WHO WILL FIND THIS REPORT USEFUL?

  • Ophthalmic Solution
  • OTC
  • World
  • MAY 04, 2018: EXPERIMENTAL IMMUNOTHERAPY FOR EYE CANCER IMPROVES SURVIVAL IN EARLY TRIALS
  • JUN 04, 2018: IMMUNOCORE PRESENTS NEW IMCGP100-102 DATA THAT SHOW DURABLE RESPONSE AND ROBUST OVERALL SURVIVAL RATE IN PATIENTS WITH METASTATIC UVEAL MELANOMA

Symptoms include dark spot on the iris, glaucoma, eye pain and eye redness.

  • Immunotherapy
  • Lung Cancer
  • Pharmaceutical
  • Targeted Therapy
  • Therapy
  • Forecast
  • 41.2.1 United Kingdom - Patients Treated with Proton Therapy Actual Number and

Currently the UK has only one Proton Therapy facility, at Clatterbridge cancer center, and it' s a low-energy' machine, only suitable for treating people with rare eye cancers.

  • Hospital
  • Specialty Hospital
  • Forecast
  • Market Size
  • Hitachi, Ltd.
  • DRUG INFUSION PUMP - PRODUCT DESCRIPTION

The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men' s health and musculoskeletal problems.

  • Clinical Trial
  • Injectable Delivery
  • Therapy
  • United States
  • Medtronic, Inc.
  • R&D Progress Research and Development Brief
  • ANTISENSE RNAI OLIGONUCLEOTIDE TO INHIBIT ICAM-1 FOR RETINAL DISEASES AND CANCER - DRUG PROFILE

These molecules are believed to play an important role in diseases of the eye, cancer, immune disorders, and inflammatory diseases.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • ANTISENSE RNAI OLIGONUCLEOTIDE TO INHIBIT HIF-1 ALPHA FOR RETINAL DISEASE AND ONCOLOGY - DRUG PROFILE

In Stage ## of Group B, a total of ## platinum-resistant ovarian cancer patients were evaluated.

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Cerulean
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

Its pipeline product portfolio includes NCT##, an antibody for the treatment of breast cancer; NCP##X, an immune-stimulatory peptide against cancer; NCN##X, a mushroom extract targeting obesity; NCN##, an anti-diabetic drug candidate; and NCB##, a biomarker candidate against bre

  • Therapy
  • United States
  • World
  • Product Initiative
  • Allergan plc
  • May 09, 2017: Oxford Finance and Silicon Valley Bank Close $20 Million Credit Facility with Castle Biosciences
  • May 09, 2017: Oxford Finance and Silicon Valley Bank Close $20 Million Credit Facility with Castle Biosciences

Castle Biosciences currently offers prognostic tests for patients with underserved cancers including cutaneous melanoma (DecisionDx®- Melanoma), an aggressive form of skin cancer, and uveal melanoma (DecisionDx®-UM and DecisionDx®-PRAME), a rare aggressive eye

  • Cancer
  • Medical Device
  • United States
  • Company
  • Castle Biosciences, Inc.
  • INDIA ELECTRORETINOGRAPHY MARKET REVENUE AND FORECASTS TO 2027 (US$ THOUSANDS)
  • 9.3 ASIA PACIFIC ELECTRORETINOGRAPHY MARKET

The other rising problems related to the eye is retinoblastoma which is a rare form of eye cancer.

  • Diagnostics
  • Electrodiagnosis
  • Healthcare
  • Forecast
  • Market Size
  • PARTNERSHIPS

The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children' s cancer, choriocarcinoma, chronic lymphocyt

  • Pharmaceutical
  • Therapy
  • United Kingdom
  • United States
  • Monopar
  • PIPELINE BY NEUROTEZ INC, H1 2019
  • PIPELINE BY JYANT TECHNOLOGIES INC, H1 2019

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Dermatological Condition
  • Diabetes
  • Pathology
  • Pharmaceutical
  • Therapy
  • PARTNERSHIPS
  • LICENSING AGREEMENTS

Its products include SG2000, SG##, AS-##-##, and conjugated PBD platform.

  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United Kingdom
  • Cancer Research Technology Limited
  • 10.3.13.1 India Ophthalmoscopes Market Revenue and Forecasts to 2027 (US$ Mn)
  • INDIA OPHTHALMOSCOPES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

THE OTHER RISING PROBLEMS RELATED TO THE EYE IS RETINOBLASTOMA WHICH IS A RARE FORM OF EYE CANCER.

  • Eye Disease
  • Eyewear
  • Medical Device
  • Forecast
  • Market Size
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • FEATURED NEWS & PRESS RELEASES

Retinoblastoma is an eye cancer that begins in the retina.

  • Cancer
  • Pathology
  • Therapy
  • United States
  • Cellceutix Corporation
  • CRYOTHERAPY MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY REGION,
  • SURGICAL APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)

It can also be effectively employed in the treatment of prostate cancer, liver cancer, bone cancer, early-stages of skin cancer, retinoblastoma (eye cancer in children), cervical cancer, kidney, and breast cancer.

  • Hospital
  • North America
  • United States
  • Forecast
  • Medtronic, Inc.
  • ACHILLES THERAPEUTICS RECEIVES RIGHTS TO DEVELOP IMMUNOTHERAPIES FOR CANCER
  • SCANCELL AND CANCER RESEARCH UK ENTER INTO AGREEMENT

Diagnosing more cancers early (stage ## and ##) is crucial to save lives.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • ASURAGEN ENTERS INTO AGREEMENT WITH CANCER RESEARCH UK, CANCER RESEARCH TECHNOLOGY AND ABCODIA

The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children' s cancer, choriocarcinoma, chronic lymphocyt

  • Cancer
  • Pathology
  • United Kingdom
  • Abcodia Ltd.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

It develops antagonists for orphan nuclear receptor steroidogenic factor-##, to treat adrenocortical cancer and Cushing' s syndrome.

  • Autoimmune Disease
  • Immunology
  • Pharmaceutical
  • Therapy
  • Lycera Corp.
  • 12.1 Factors impacting market growth

Excessive UV exposure can increase the risk of eye diseases such as cataract and eye cancers.

  • Body Care
  • Personal Hygiene
  • Skin Care
  • World
  • Ashland Inc.
  • ASURAGEN ENTERS INTO AGREEMENT WITH CANCER RESEARCH UK, CANCER RESEARCH TECHNOLOGY AND ABCODIA

The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children' s cancer, choriocarcinoma, chronic lymphocyt

  • Cancer
  • Medical Device
  • Medical Equipment
  • Molecular Diagnostics
  • Asuragen, Inc.
  • PARTNERSHIPS

The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children' s cancer, choriocarcinoma, chronic lymphocyt

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • PARTNERSHIPS

The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children' s cancer, choriocarcinoma, chronic lymphocyt

  • Pharmaceutical
  • Therapy
  • United Kingdom
  • United States
  • Monopar
  • Handok Pharma Enters Into Co-Marketing Agreement With Novartis Korea For Onbrez Breezhaler

Gatiflo (gatifloxacin) ophthalmic solution is used to treat eye infections such as bacterial conjunctivitis, meibomitis, keratitis and the sterilization of bacteria in the eye before and after eye surgery.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • South Korea
  • Handok Pharmaceuticals Co., Ltd.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • FEATURED NEWS & PRESS RELEASES

Retinoblastoma is an eye cancer that begins in the retina.

  • Cancer
  • Pathology
  • Therapy
  • United States
  • Cellceutix Corporation
  • Forecast
  • UNITED KINGDOM - ACTUAL PATIENT TREATED WITH PROTON THERAPY (NUMBER), 2013 - 2016

CURRENTLY THE UK HAS ONLY ONE PROTON THERAPY FACILITY, AT CLATTERBRIDGE CANCER CENTER, AND IT' S A LOW-ENERGY' MACHINE, ONLY SUITABLE FOR TREATING PEOPLE WITH RARE EYE CANCERS.

  • Hospital
  • Specialty Hospital
  • Forecast
  • Market Size
  • Hitachi, Ltd.
  • OWLSTONE MEDICAL ENTERS INTO AGREEMENT WITH CANCER RESEARCH UK

The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children' s cancer, choriocarcinoma, chronic lymphocyt

  • Biopsy
  • Cancer
  • Medical Equipment
  • United Kingdom
  • AstraZeneca PLC
  • Objective
  • Market definition

Skin cancer is one of the most common cancers found in the US.

  • Cancer
  • World
  • Carl Zeiss Meditec AG
  • Eckert & Ziegler AG
  • Varian Medical Systems, Inc.
  • 6.5.2 EYE CANCER
  • SYMPTOMS AND TREATMENT FOR EYE CANCER

Asia-Pacific Ophthalmic Drugs & Devices Market Forecast 2017-2025 ## RESEARCH SCOPE ##. ## STUDY GOALS ##. ## SCOPE OF MARKET STUDY ##. ## WHO WILL FIND THIS REPORT USEFUL?

  • OTC
  • APAC
  • LICENSING AGREEMENTS

The center provides treatments for macular, retinal and optic nerve diseases, cataracts, eye infections, eye cancers and eye diseases in children.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Amarantus BioScience Holdings, Inc.